These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33426833)

  • 21. Pediatric Dispersible Tablets: a Modular Approach for Rapid Prototyping.
    Buck J; Huwyler J; Kühl P; Dischinger A
    Pharm Res; 2016 Aug; 33(8):2043-55. PubMed ID: 27251416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Necessity of rethinking oral pediatric formulations.
    Bar-Shalom D
    Clin Ther; 2014 Feb; 36(2):180-3. PubMed ID: 24529290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatric Formulation Initiative: selected reports from working groups.
    Giacoia GP; Taylor-Zapata P; Mattison D
    Clin Ther; 2008 Nov; 30(11):2097-101. PubMed ID: 19108797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations.
    Giacoia GP; Taylor-Zapata P; Zajicek A
    Clin Ther; 2012 Nov; 34(11):S1-10. PubMed ID: 23149008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulation Challenges and Strategies to Develop Pediatric Dosage Forms.
    Malkawi WA; AlRafayah E; AlHazabreh M; AbuLaila S; Al-Ghananeem AM
    Children (Basel); 2022 Apr; 9(4):. PubMed ID: 35455532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age-Appropriate Pediatric Dosage Forms in Japan: Insights into End-User Perceptions From an Observational Cross-Sectional Survey Assessing the Acceptability of Oral Formulation.
    Saito J; Akabane M; Komura M; Nakamura H; Ishikawa Y
    Ther Innov Regul Sci; 2019 Jul; 53(4):455-471. PubMed ID: 30157669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a Pediatric Mini-Tablet Formulation for Expedited Preclinical Studies.
    Lavan M; Wang X; McCain R; Jannasch A; Cooper B; Hostetler S; Byrn S; Knipp G
    AAPS PharmSciTech; 2021 Jan; 22(1):40. PubMed ID: 33417081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3D printing: An appealing route for customized drug delivery systems.
    Elkasabgy NA; Mahmoud AA; Maged A
    Int J Pharm; 2020 Oct; 588():119732. PubMed ID: 32768528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulation development of a continuously manufactured orodispersible film containing warfarin sodium for individualized dosing.
    Niese S; Quodbach J
    Eur J Pharm Biopharm; 2019 Mar; 136():93-101. PubMed ID: 30660692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ease of use and acceptability of a new pen device for the administration of growth hormone therapy in pediatric patients: an open-label, uncontrolled usability test.
    Fuchs GS; Mikkelsen S; Knudsen TK; Kappelgaard AM
    Clin Ther; 2009 Dec; 31(12):2906-14. PubMed ID: 20110030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Issues impacting therapeutic outcomes in pediatric patients: an overview.
    Kalra A; Goindi S
    Curr Pediatr Rev; 2014; 10(3):184-93. PubMed ID: 25088338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pediatric drugs--a review of commercially available oral formulations.
    Strickley RG; Iwata Q; Wu S; Dahl TC
    J Pharm Sci; 2008 May; 97(5):1731-74. PubMed ID: 17823956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opportunities for enteral drug delivery for neonates, infants, and toddlers: a critical exploration.
    Kaneria NS; Tuleu C; Ernest T
    Expert Opin Drug Deliv; 2022 May; 19(5):475-519. PubMed ID: 35404191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Administering drugs to infants, children, and adolescents].
    Wagner R; Frey OR
    Ther Umsch; 2006 Jun; 63(6):411-8. PubMed ID: 16841578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using the Slug Mucosal Irritation Assay to Investigate the Tolerability of Tablet Excipients on Human Skin in the Context of the Use of a Nipple Shield Delivery System.
    Kendall R; Lenoir J; Gerrard S; Scheuerle RL; Slater NK; Tuleu C
    Pharm Res; 2017 Apr; 34(4):687-695. PubMed ID: 28194635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A review of topically administered mini-tablets for drug delivery to the anterior segment of the eye.
    Moosa RM; Choonara YE; du Toit LC; Kumar P; Carmichael T; Tomar LK; Tyagi C; Pillay V
    J Pharm Pharmacol; 2014 Apr; 66(4):490-506. PubMed ID: 24635554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New Orodispersible Mini Tablets of Enalapril Maleate by Direct Compression for Pediatric Patients.
    Ortega CA; Favier LS; Cianchino VA; Cifuente DA
    Curr Drug Deliv; 2020; 17(6):505-510. PubMed ID: 32384031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How close is the dose? Manipulation of 10 mg hydrocortisone tablets to provide appropriate doses to children.
    Watson C; Webb EA; Kerr S; Davies JH; Stirling H; Batchelor H
    Int J Pharm; 2018 Jul; 545(1-2):57-63. PubMed ID: 29705101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mimicking the Impact of Infant Tongue Peristalsis on Behavior of Solid Oral Dosage Forms Administered During Breastfeeding.
    Scheuerle RL; Kendall RA; Tuleu C; Slater NKH; Gerrard SE
    J Pharm Sci; 2017 Jan; 106(1):193-199. PubMed ID: 27686681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel delivery device for monolithical solid oral dosage forms for personalized medicine.
    Wening K; Breitkreutz J
    Int J Pharm; 2010 Aug; 395(1-2):174-81. PubMed ID: 20635515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.